[1] 陈正辉,刘淑敏,杜艳.携带blaNDM-1基因的肠杆菌科细菌耐药流行特征分析[J].中国抗生素杂志.2018,(10).
[2] 李媛睿,刘婧娴,俞静,等.应用基质辅助激光解析电离飞行时间质谱检测产碳青霉烯酶肠杆菌科细菌对厄他培南的水解能力[J].中国感染与化疗杂志.2016,(5).DOI:10.16718/j.1009-7708.2016.05.014 .
[3] 陈金云,傅鹰,杨青,等.KPC-2及 IMP-4酶介导肠杆菌科细菌碳青霉烯类耐药研究[J].中华微生物学和免疫学杂志.2015,(6).DOI:10.3760/cma.j.issn.0254-5101.2015.06.004 .
[4] Wenxia Zhang,Yan Guo,Yang Yang,等.Study of In Vitro Synergistic Bactericidal Activity of Dual β-Lactam Antibiotics Against KPC-2-Producing Klebsiella pneumoniae[J].Microbial drug resistance: MDR : Mechanisms, epidemiology, and disease.2020,26(3).204-210.DOI:10.1089/mdr.2019.0126 .
[5] De Angelis, G.,Grossi, A.,Menchinelli, G.,等.Rapid molecular tests for detection of antimicrobial resistance determinants in Gram-negative organisms from positive blood cultures: a systematic review and meta-analysis[J].Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases.2020,26(3).271-280.DOI:10.1016/j.cmi.2019.11.009 .
[6] Andrea Novelli,Paola Del Giacomo,Gian Maria Rossolini,等.Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination[J].Expert review of anti-infective therapy.2020,18(7).643-655.DOI:10.1080/14787210.2020.1756775 .
[7] M M,Sfeir,J A,Hayden,K A,Fauntleroy,等.EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing Enterobacteriaceae.[J].Journal of Clinical Microbiology.2019,57(5).DOI:10.1128/JCM.01757-18 .
[8] Alen,Krajnc,Jürgen,Brem,Philip,Hinchliffe,等.Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases.[J].Journal of Medicinal Chemistry.2019,62(18).8544-8556.DOI:10.1021/acs.jmedchem.9b00911 .
[9] Glupczynski, Youri,Evrard, Stephanie,Huang, Te-Din,等.Evaluation of the RESIST-4 K-SeT assay, a multiplex immunochromatographic assay for the rapid detection of OXA-48-like, KPC, VIM and NDM carbapenemases[J].The Journal of Antimicrobial Chemotherapy.2019,74(5).1284-1287.DOI:10.1093/jac/dkz031 .
[10] Karen Bush,Patricia A. Bradford.Interplay between β-lactamases and new β-lactamase inhibitors[J].Nature reviews. Microbiology.2019,17(5).295-306.DOI:10.1038/s41579-019-0159-8 .
相关知识
中国碳青霉烯类耐药肠杆菌科细菌的流行病学和防控策略
俞云松教授团队:厄他培南单药耐药CRE菌株的分子流行病学特征与治疗策略丨ESCMID Global 2024
永不落幕的IDWeek丨新型β
这个细菌太棘手:质谱搞不定,生化鉴定无反应
呼吸与共,感染同行——2023年呼吸系统感染性疾病诊疗进展回顾丨年度盘点·呼吸篇
咳黄脓痰就是细菌感染?是否一定要抗菌治疗?看看指南怎么说!
草绿色链球菌十分常见,这些疑问大多数人却搞不清楚
手把手教你看懂,细菌药敏检验报告
呼吸感染性疾病诊治年度进展:从流行现状与疾病控制、机制认识与检测技术、药物研发与治疗手段、疾病预防与康复理念四方面看重要研究成果
玫瑰杆菌科细菌Dinoroseobacter shibae DFL 12抑制溶藻弧菌Vibrio alginolyticus ATCC33787群体感应行为的研究
网址: 肠杆菌目细菌碳青霉烯酶的实验室检测和临床报告规范专家共识(第二版) https://m.huajiangbk.com/newsview528342.html
上一篇: 如何防治仙客来的细菌性病害 |
下一篇: 银屑病与细菌感染有什么联系? |